Dozens of over-the-counter acne products had very high levels of the known carcinogen benzene, even when they were taken ...

Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.

The stock's rise snapped a five-day losing streak.

The co-founder of biotech firm Regeneron Pharmaceuticals (REGN) said in a newspaper interview that popular weight-loss drugs ...

Regeneron, a leading biotech firm, is testing a drug called trevogrumab to preserve lean muscle while using these medications ...

Regeneron's CSO George Yancopoulos warns that GLP-1 weight-loss drugs like Ozempic may lead to rapid muscle loss, increasing ...

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...

Regeneron Pharmaceuticals (REGN) said it currently expects that financial results for the third quarter 2024 will include an acquired ...

With its purchase of the former million-square-foot Quad plant in Saratoga Springs, Regeneron Pharmaceuticals has easily ...

Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...

Regeneron Pharmaceuticals Inc. shares are headed for their biggest monthly drop since mid-2022 after a legal setback that ...